The Use of Psychotropic Medications with Breastfeeding Women - Contemporary Nurse: Healthcare Across the Lifespan

The Use of Psychotropic Medications with Breastfeeding Women: Applying the available evidence

References

American Academy of Pediatrics (2005) Breastfeeding and the use of human milk: policy statement. Pediatrics 115(2): 496-506.

Appleby L, Warner R, Whitton A and Faragher B (1997) A controlled study of fluoxetine and cognitive-behavioural counseling in the treatment of PND. British Medical Journal 314: 932-936.

Austin M-PV, Mitchell PB (1998) Use of psychotropic medications in breast-feeding women: acute and prophylactic treatment. Australian and New Zealand Journal of Psychiatry 32: 778-784.

Boath E, Bradley E and Henshaw C (2004) Women's views of antidepressants in the treatment of postnatal depression. Journal of Psychosomatic Obstetrics and Gynaecology 25(3-4): 221-233.

Bryant B, Knights K and Salerno E (2003) Pharmacology for Health Professionals, Mosby, Sydney.

Burt V, Suri R, Altschuler L, Stowe Z, Hendrick V and Muntean E (2001) The use of psychotropic medications during breast-feeding. American Journal of Psychiatry 158(7): 1001-1009.

Chaudron LH and Jefferson JW (2000) Mood stabilizers during breastfeeding: a review. Journal of Clinical Psychiatry 61(2): 78-89.

Chaves RG and Lamounier JA (2004) Breastfeeding and maternal medications. Journal of Pediatrics 80(5): S189-198.

Craig M and Abel K (2001) Prescribing for psychiatric disorders in pregnancy and lactation. Best Practice & Research Clinical Obstetrics and Gynaecology 15(6): 1013-1030.

Elwood PC, Pickering J, Gallacher JEJ, Hughes J and Davies D (2005) Long term effect of breast feeding: cognitive function in the Caerphilly cohort. Journal of Epidemiology & Community Health 59: 130-133.

Ernst CL and Goldberg JF (2002) The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropics. Journal of Clinical Psychiatry 63(suppl 4): 42-55.

Gentile S (2004) Clinical utilization of atypical antipsychotics in pregnancy and lactation. The Annals of Pharmacotherapy 38(7): 1265-1271.

Gjere NA (2001) Psychopharmacology in pregnancy. Journal of Perinatal & Neonatal Nursing 14(4): 12-25.

Hale TW (2002) Medications and mothers' milk 10^th edn. Amarillo, Texas: Pharmasoft.

Hale TW (2004) Maternal medications during breastfeeding. Clinical Obstetrics and Gynaecology 47(3): 696-711.

Hoffbrand S, Howard L and Crawley H (2001) Antidepressant treatment for post-natal depression. The Cochrane Database of Systematic Reviews Issue 2: Art. No CD002018. DOI: 10.1002/14651858.CD002018.

Howard L and Abel KM (2004) Safety of antipsychotic drugs for pregnant and breastfeeding women with non-affective psychosis. Editorial. British Medical Journal 329: 933-934.

Ilett KF, Hackett LP, Kristensen JH, Vaddadi KS, Gardiner SJ and Begg EJ (2004) Transfer of Risperidone and 9-Hydroxyrisperidone into human milk. The Annals of Pharmacotherapy 38: 273-276.

Iqbal MM, Gudlapalli SP, Ryan WG, Ryals T, Passman TE (2001) Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants. Southern Medical Journal 94(3): 304-322.

Lee A, Giesbrecht E, Dunn E and Ito S (2004) Letters to the Editor. Excretion of Quetiapine in breast milk. American Journal of Psychiatry 161(9): 1715-1716.

Malone K, Papagni K, Ramini S and Keltner N L (2004) Antidepressants, antipsychotics, benzodiazepines, and the breastfeeding dyad. Perspectives in Psychiatric Care 40(2): 73-86.

McKenna K, Einarson A, Levinson A and Gideon K (2004) Significant changes in antipsychotic drug use during pregnancy. Veterinary & Human Toxicology 46(1): 44-46.

Oates M (2003) Perinatal psychiatric disorders: a leading cause of maternal morbidity and mortality. The British Medical Bulletin 67: 219-229.

Olds SB, London ML, Ladewig PW and Davidson MR (2004) Maternal-Newborn Nursing and Women's Health Care 7^th edn. Upper Saddle River: Prentice Hall.

Piontek CM, Baab S, Peindl KS and Wisner K (2000) Serum valproate levels in six breastfeeding mother-infant pairs. Journal of Clinical Psychiatry 61(3): 170-172.

Spear HJ (2004) When reality does not meet expectations: the importance of consistent communication, support, and anticipatory guidance for high-risk mothers who plan to breastfeed. Journal of Clinical Nursing 13: 773-775.

Sved Williams A (2004) Infants of mothers with mental illness. In Cowling V (ed) Children of Parents with Mental Illness 2: Personal and Clinical Perspectives, pp.17-40. Melbourne: ACER Press.

Tenyi T, Csabi G and Trixler M (2000) Antipsychotics and Breast-Feeding: A Review of the Literature. Paediatric Drugs 2(1): 23-28.

Therapeutic Guidelines Ltd (2003) Therapeutic Guidelines: Psychotropic 5^th edn. North Melbourne: Therapeutic Guidelines Ltd.

Trixler M and Tenyi T (1997) Antipsychotic use in pregnancy. Drug Safety 16(6): 403-410.

Viguera AC and Cohen LS (1998) The course and management of bipolar disorder during pregnancy. Psychopharmacology Bulletin 34(3): 339-353.

Welch R and Findlay J (1981) Excretion of drugs in human breast milk. Drug Metabolism Review 12: 261-277.

Winans E (2001) Antipsychotics and breastfeeding. Journal of Human Lactation 17(4): 344-347.

Yoshida K, Smith B, Craggs M and Kumar R (1998) Neuroleptic drugs in breast-milk: a study of pharmacokinetics and of possible adverse effects in breast-fed infants. Psychological Medicine 28: 81-91.